Table 1.
Baseline and Treatment Characteristics
n= | % | |||
---|---|---|---|---|
|
||||
Age | ||||
median | (range) | 61 | (33–77) | |
Gender | ||||
Male | 4 | 33 | ||
Female | 8 | 67 | ||
Primary Tumor site | ||||
Head/Neck | 2 | 17 | ||
Abdomen/Pelvis | 6 | 50 | ||
Extremeties | 4 | 33 | ||
Histology | ||||
Hemangiopericytoma | 2 | 17 | ||
Rhabdomyosarcoma | 1 | 8 | ||
Leiomyosarcoma | 6 | 50 | ||
Myxoid Fibrosarcoma | 2 | 17 | ||
Myxoid Liposarcoma | 1 | 8 | ||
KPS | ||||
80 | 10 | 83 | ||
90 | 2 | 17 | ||
Disease Extent at Spine RT Start | ||||
Single metastatic site | 0 | 0 | ||
Disseminated spine/bone only | 2 | 17 | ||
Bone and Visceral sites | 10 | 83 | ||
Treated Spinal Site | ||||
Thoracic Spine | 2 | 17 | ||
Lumbar Spine | 8 | 67 | ||
Sacrum | 2 | 17 | ||
RT Dose x Fraction | ||||
24 Gy x 1 | 7 | 58 | ||
9 Gy x 3 | 4 | 33 | ||
10 Gy x 3 | 1 | 8 | ||
BED | ||||
Median | (range) | 81.6 | (51.3–81.6) | |
GTV Volume (cm3) | ||||
Median | (range) | 6.6 | (1.0–46.5) | |
PTV Volume (cm3) | ||||
Median | (range) | 115.1 | (7.6–203.2) | |
Systemic Therapy Post-RT | ||||
Yes | 10 | 83 | ||
No | 2 | 17 |